KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.99

Ixekizumab provides persistent improvements in health-related quality of life and the sexual impact associated with moderate-to-severe genital psoriasis in adult patients during a 52-week, randomised, placebo-controlled, phase 3 clinical trial.

C Ryan, L Guenther, P Foley, J Weisman, R T Burge, G Gallo, K See, M McKean-Matthews, C C Bertram, J F Merola

J Eur Acad Dermatol Venereol 36(4) e277-e279

PMID34812561
PMCIDPMC9299771
DOI10.1111/jdv.17836
发表日期2021-11-23
入排依据:记录类型属于综述、Meta 分析、社论、评论、病例或指南。
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。